GE HealthCare Technologies Inc. (GEHC)

NASDAQ: GEHC · Real-Time Price · USD
84.74
-0.26 (-0.31%)
At close: Jan 17, 2025, 4:00 PM
84.60
-0.14 (-0.17%)
After-hours: Jan 17, 2025, 6:48 PM EST
-0.31%
Market Cap 38.72B
Revenue (ttm) 19.56B
Net Income (ttm) 1.68B
Shares Out 456.87M
EPS (ttm) 3.65
PE Ratio 23.22
Forward PE 18.69
Dividend $0.14 (0.17%)
Ex-Dividend Date Jan 14, 2025
Volume 2,853,764
Open 86.33
Previous Close 85.00
Day's Range 84.58 - 86.34
52-Week Range 71.31 - 94.55
Beta 1.30
Analysts Buy
Price Target 96.00 (+13.29%)
Earnings Date Feb 13, 2025

About GEHC

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women’s health p... [Read more]

Sector Healthcare
Founded 1892
Employees 51,000
Stock Exchange NASDAQ
Ticker Symbol GEHC
Full Company Profile

Financial Performance

In 2023, GEHC's revenue was $19.55 billion, an increase of 6.60% compared to the previous year's $18.34 billion. Earnings were $1.39 billion, a decrease of -27.71%.

Financial Statements

Analyst Forecast

According to 14 analysts, the average rating for GEHC stock is "Buy." The 12-month stock price forecast is $96.0, which is an increase of 13.29% from the latest price.

Price Target
$96.0
(13.29% upside)
Analyst Consensus: Buy
Stock Forecasts

News

China External Cardiology Remote Monitors Market Outlook to 2033, with Key Companies Shenzhen Mindray Bio-Medical Electronics Co., Nihon Kohden and GE HealthCare Technologies

Dublin, Jan. 20, 2025 (GLOBE NEWSWIRE) -- The "China External Cardiology Remote Monitors Market Outlook to 2033" report has been added to ResearchAndMarkets.com's offering. The comprehensive databook ...

12 hours ago - GlobeNewsWire

University of California San Francisco and GE HealthCare Launch a Joint Research Program to Drive Innovations in Imaging, Brain Health and Precision Oncology

SAN FRANCISCO--(BUSINESS WIRE)--University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE HealthCare today announced the launch of a Care Innovation Hub, a joi...

5 days ago - Business Wire

Sutter Health and GE HealthCare enter strategic partnership to benefit patients, physicians and clinicians with advanced, AI-powered imaging

SACRAMENTO, Calif.--(BUSINESS WIRE)--Sutter Health and GE HealthCare (Nasdaq: GEHC) today announced a seven-year strategic enterprise partnership, known as a Care Alliance, that aims to increase acces...

6 days ago - Business Wire

GE HealthCare Stock Gains After Jefferies Analysts Name It 'Franchise Pick'

GE HealthCare Technologies (GEHC) shares gained Wednesday after Jefferies analysts called the stock a “franchise pick” and made a bullish case for the company's diagnostic imaging business.

12 days ago - Investopedia

Stock Of The Day: Where Will The GE HealthCare Rally End?

GE HealthCare Technologies Inc.  GEHC shares are trading higher Wednesday. The stock was upgraded from Hold to Buy, while the price target was raised from $95 to $103 by Jefferies.

12 days ago - Benzinga

United States External Cardiology Remote Monitors Market Outlook to 2033 Featuring Key Players, GE HealthCare, Shenzhen Mindray Bio-Medical Electronics, and Nihon Kohden

Dublin, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The "United States External Cardiology Remote Monitors Market Outlook to 2033" report has been added to ResearchAndMarkets.com's offering. The databook report...

18 days ago - GlobeNewsWire

2025 Could Be GE HealthCare's Year With Emphasis On Efficiency And AI Broadens

GE HealthCare shares have surged nearly 27% since October 2023, driven by AI-driven strategies and innovation in healthcare diagnostics, despite some volatility in revenue growth. The bullish outlook ...

4 weeks ago - Seeking Alpha

GE HealthCare to announce fourth quarter and full year 2024 results on February 13, 2025

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its fourth quarter and full year 2024 financial results before the market opens on Thursday, February 13, 2025. The GE HealthCare m...

5 weeks ago - Business Wire

GE HealthCare: Growth Acceleration In 2025 Can Drive Stock Higher

GE HealthCare Technologies is rated a buy due to strong growth prospects, a healthy backlog, and favorable valuation compared to peers. The company's revenue growth is supported by new product innovat...

6 weeks ago - Seeking Alpha

GE HealthCare Expands Its Effortless Recon DL Portfolio, Bringing Advanced Deep Learning Image Reconstruction to Clinicians Worldwide

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) unveiled three new advanced deep learning image processing and reconstruction solutions as a part of its Effortless Recon DL portfolio at the Rad...

6 weeks ago - Business Wire

GE HealthCare showcases commitment to sustainable innovation at RSNA 2024

CHICAGO--(BUSINESS WIRE)--As part of a companywide commitment to advance innovation that improves the health of patients and the planet, GE HealthCare (Nasdaq: GEHC) is highlighting several solutions ...

6 weeks ago - Business Wire

Trade Tracker: Stephanie Link sells Lam Research, GE Healthcare and buys more Gap, CrowdStrike

Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to reveal her latest portfolio moves.

Other symbols: CRWDLRCXGAP
6 weeks ago - CNBC Television

GE HealthCare announces 510(k) submission for CleaRecon DL technology designed to improve image quality in the interventional suite with AI-based reconstruction

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced today the 510(k) submission to the U.S. Food and Drug Administration for CleaRecon DL, deep learning technology, designed to improve th...

6 weeks ago - Business Wire

GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical

CHALFONT ST GILES, England--(BUSINESS WIRE)--GE HealthCare to acquire remaining 50% stake in Nihon Medi-Physics (NMP), a leading radiopharmaceutical company in Japan, from Sumitomo Chemical.

7 weeks ago - Business Wire

GE HealthCare Unveils Sonic DL for 3D, Expanding Deep Learning Innovations in MRI

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today unveiled Sonic DL for 3Dii, the newest addition to its effortless imaging portfolio, designed to accelerate MRI scans across a wide range o...

7 weeks ago - Business Wire

GE HealthCare Highlights New Solutions Including AI-enabled Innovations to Drive Precision Care at RSNA 2024

CHICAGO--(BUSINESS WIRE)--At the Radiological Society of North America's (RSNA) 2024 Annual Meeting taking place from Dec. 1-4 in Chicago, GE HealthCare (Nasdaq: GEHC) will exhibit more than 40 innova...

7 weeks ago - Business Wire

GE HealthCare unveils Pristina Via to streamline technologist workflow and improve patient-centered breast care

CHICAGO--(BUSINESS WIRE)--Today GE HealthCare announced the new Pristina Via™* mammography system designed to enhance the screening experience for both technologists and patients. Debuting at the Radi...

7 weeks ago - Business Wire

GE HealthCare management to present at upcoming investor conferences

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences. Nasdaq Investor Conference in Lond...

2 months ago - Business Wire

GE HealthCare Announces Advanced Imaging Innovations for OEC 3D C-arm to Help Improve Precision Care in Practice of Interventional Pulmonology

CHICAGO--(BUSINESS WIRE)--GE HealthCare announces additional clinical applications now available as part of the OEC 3D mobile CBCT C-arm portfolio.

2 months ago - Business Wire

GE HealthCare Guidance Was Good. The Stock Dropped Anyway.

GE HealthCare hosted an analyst event on Thursday. Solid guidance fell on deaf ears.

2 months ago - Barrons

FDA clears XENOVIEW® 3T Chest Coil in GE HealthCare MRI Systems

Expands accessibility for institutions utilizing GE HealthCare MRI systems Expands accessibility for institutions utilizing GE HealthCare MRI systems

2 months ago - GlobeNewsWire

GE HealthCare hosts 2024 Investor Day: focus on innovation to deliver precision care and drive growth

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will host its Investor Day today at Nasdaq MarketSite in New York, NY. The event begins at 8:00 am ET / 7:00 am CT and can be viewed virtually he...

2 months ago - Business Wire

Pilot Study Showcases the Value of Portrait Mobile Continuous Monitoring Solution to Encourage Clinical Intervention While Mitigating Alarm Fatigue

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the publication of data from a two-phase pilot study conducted with Cleveland Clinic in the peer-reviewed Journal of Clinical Ane...

2 months ago - Business Wire

GE HealthCare Receives FDA Clearance for Head-Only SIGNA MAGNUS 3.0T MRI System

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA™ MAGNUS,i a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner....

2 months ago - Business Wire

GE HealthCare Announces Initiative to Help Address Radiologic Technologist Shortage

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an initiative with AMN Healthcare aimed at helping address the critical shortage of radiologic technologists (rad tech) in the he...

2 months ago - Business Wire